EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
HOOKIPA Pharma Inc. (HOOK) had EBITDA Margin of -371.33% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$9.70M |
|
$-13.84M |
|
-- |
|
$9.70M |
|
$46.41M |
|
$-36.70M |
|
$22.87M |
|
$-13.84M |
|
$-18.84M |
|
$-13.84M |
|
$-13.84M |
|
$-13.84M |
|
$-18.84M |
|
$-36.70M |
|
$-36.02M |
|
12.65M |
|
12.65M |
|
$-1.09 |
|
$-1.09 |
|
| Balance Sheet Financials | |
$41.73M |
|
-- |
|
$0.13M |
|
$41.86M |
|
$6.58M |
|
-- |
|
$2.76M |
|
$9.34M |
|
$32.52M |
|
$32.52M |
|
$32.52M |
|
12.38M |
|
| Cash Flow Statement Financials | |
$-11.50M |
|
$6.81M |
|
$-0.48M |
|
$39.89M |
|
$37.42M |
|
$-2.46M |
|
$0.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-378.36% |
|
-378.36% |
|
|
EBITDA Margin |
-371.33% |
-142.62% |
|
-142.63% |
|
$-4.69M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
-- |
|
4.37 |
|
83.53 |
|
-42.55% |
|
-42.55% |
|
-33.06% |
|
-42.55% |
|
$2.63 |
|
$-0.37 |
|
$-0.91 |
|